Target intelligence / Profile preview

SUMO-interacting motif-containing protein 1 (SIMC1)

Target
SIMC1
Molecular classification
Other (non-canonical chromatin-associated protein), Adaptor/scaffold protein
01

Overview

SUMO-interacting motif-containing protein 1 (SIMC1) is a human protein encoded by the SIMC1 gene (also known as C5orf25, PLEIAD, OOMA1, FLJ44216). It contains multiple SUMO-interacting motifs (SIMs) enabling it to bind to SUMO polymers and associate with SUMO-rich bodies such as PML (promyelocytic leukemia) nuclear bodies. SIMC1 acts as a regulatory subunit for the SMC5/6 structural maintenance of chromosomes complex, particularly in the human antiviral response. Through its interaction with the SLF2 protein, SIMC1 forms an Nse5/6-like complex essential for SMC5/6 recruitment to sites of viral replication, thus helping restrict viral genome persistence. It also exhibits peptidase inhibitor activity. Mutations or alterations in SIMC1 are associated with rare diseases such as mucopolysaccharidosis type IIId and renal-hepatic-pancreatic dysplasia, and it may be involved in genomic stability mechanisms relevant to cancer and alternative telomere lengthening. There are currently no drugs or small molecules specifically known to target SIMC1, nor established biomarkers or safety concerns associated with its therapeutic targeting[2][3][4].

Other names
SUMO-interacting motif-containing protein 1SIMC1C5orf25PLEIADFLJ44216OOMA1Platform element for inhibition of autolytic degradationoocyte maturation associated 1
02

Mechanism of action

Not established for small molecule drugs (as of latest available data) SIMC1 recruits the SMC5/6 complex via SUMO-binding domains to sites of viral replication, restricting viral genome maintenance in mammalian cells[2][4]

03

Biological functions

SUMO polymer bindingPeptidase inhibitor activityRecruitment of SMC5/6 complex for viral restrictionProtein complex assembly (e.g., with SLF2)
04

Disease associations

Cancer (recruitment to PML bodies, implicated in telomere maintenance in ALT cancers[2])Viral infection/antiviral restriction (directs SMC5/6 to sites of viral replication[2][4])Mucopolysaccharidosis, type IIId[3]Renal-Hepatic-Pancreatic Dysplasia[3]

Beyond the preview

Go deeper on SUMO-interacting motif-containing protein 1 (SIMC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SUMO-interacting motif-containing protein 1 (SIMC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call